Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01716130 · ClinicalTrials.gov registry record
Acceptability of Fluzone Intradermal Vaccine to Patients and Vaccine Administrators
A clinical trial of Patient Response to Fluzone ID Vaccine, sponsored by Touro University, California.
- Completed
- Registry status
- 249
- Enrollment target
- 1
- Study location
NCT01716130 is a study of Patient Response to Fluzone ID Vaccine that has completed, run by Touro University, California. The registered enrollment target is 249 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01716130, a study of Patient Response to Fluzone ID Vaccine, has completed, sponsored by Touro University, California.
- COMPLETED
- Registry status
- 249 participants
- Enrollment target
- 1
- Study location
Study Summary
To assess the acceptance of the Fluzone Intradermal (ID)vaccine in adults and vaccine administrators in the United States. Patients completed 2 surveys, one immediately post-vaccination and one seven days later, that documented demographics and assessed their injection pain, injection anxiety, speed of injection, overall satisfaction, and preference for next year's vaccine. Vaccine administrators completed one survey assessing ease of vaccine preparation and administration, time required to administer, and safety/risk of needle stick injury for patient and administrator.
Conditions Studied
Study Locations (1)
California
- Touro University California - Vallejo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 249 participants |
| Start Date | 2011-10 |
| Est. Completion | 2011-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01716130
The ClinicalTrials.gov registry entry for NCT01716130 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 249 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Touro University, California, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Patient Response to Fluzone ID Vaccine appearing as the primary indexed condition, and to 0 interventions.
NCT01716130 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01716130 about?
NCT01716130 is a clinical study titled "Acceptability of Fluzone Intradermal Vaccine to Patients and Vaccine Administrators". To assess the acceptance of the Fluzone Intradermal (ID)vaccine in adults and vaccine administrators in the United States. Patients completed 2 surveys, one immediately post-vaccination and one seven days later, that documented demographics and assessed their injection pain, injection anxiety, speed...
What is the current status of trial NCT01716130?
This trial is currently completed. The enrollment target is 249 participants. The study started on 2011-10. Estimated completion is 2011-11.
What conditions does trial NCT01716130 study?
This clinical trial studies the following conditions: Patient Response to Fluzone ID Vaccine.
Who is sponsoring clinical trial NCT01716130?
This trial is sponsored by Touro University, California, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01716130 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.